Leonard J. Sokolow - 20 Jun 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Reporting relationship: Director
Issuer ticker: VVOS
Reported as of: 20 Jun 2024
Net transaction value: +$9,520
SEC form: 4
Accepted by SEC: 28 Jun 2024, 20:53:50 UTC
Prior SEC filing: 26 Apr 2024
Next SEC filing: 13 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Bradford K. Amman as attorney-in-fact for Leonard J. Sokolow

Key filing fact

Leonard J. Sokolow filed Form 4 for Vivos Therapeutics, Inc. (VVOS) on 28 Jun 2024.

Key facts

This page summarizes Leonard J. Sokolow's Form 4 filing for Vivos Therapeutics, Inc. (VVOS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Jun 2024, 20:53.

Change

Previous filing in this sequence was filed on 26 Apr 2024.
Current net transaction value: +$9,520.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VVOS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $9,520
Shares: +4,000
Change %: +115%
Price: $2.38
Shares after: 7,467
Date: 20 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,000
Exercise price: $2.38
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 20, 2024, the Reporting Person received a grant of 4,000 stock options from the Issuer. One-half vested immediately, one-fourth will vest on September 30, 2024 and one-fourth will vest on December 31, 2024.